CDX2 is an amplified lineage-survival oncogene in colorectal cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 46, 2012, Pages

  Salari, Keyan ^a   Spulak, Mary E ^a   Cuff, Justin ^a   Forster, Andrew D ^a   Giacomini, Craig P ^a   Huang, Stephanie ^a   Ko, Melissa E ^a   Lin, Albert Y ^b   De Rijn, Mattvan ^a   Pollack, Jonathan R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

13q amplification; CDK8; Integrative genomics; Lineage dependency; Lineage addiction oncogene

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR CDX2; WNT PROTEIN;

ARTICLE; BINDING SITE; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 13Q; COLORECTAL CANCER; CONTROLLED STUDY; GENE AMPLIFICATION; GENE TARGETING; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 13; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; GENE AMPLIFICATION; HOMEODOMAIN PROTEINS; HUMANS; MICE; NIH 3T3 CELLS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; WNT SIGNALING PATHWAY;

EID: 84869224866     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1206004109     Document Type: Article

References (66)

1. American Cancer Society (2011) Cancer Facts & Figures 2011 (American Cancer Society, Atlanta).
2. Vogelstein B, et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319(9):525-532.
3. Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386(6625):623-627.
4. Walther A, Houlston R, Tomlinson I (2008) Association between chromosomal instability and prognosis in colorectal cancer: A meta-analysis. Gut 57(7):941-950.
5. Popat S, Houlston RS (2005) A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer 41(14):2060-2070.
6. Grady WM, Carethers JM (2008) Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135(4):1079-1099.
7. Rajagopalan H, et al. (2002) Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418(6901):934.
8. Sjöblom T, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314(5797):268-274.
9. Wood LD, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318(5853):1108-1113.
10. Camps J, et al. (2009) Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes Chromosomes Cancer 48(11):1002-1017.
11. Douglas EJ, et al. (2004) Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 64(14):4817-4825.
12. Kim MY, et al. (2006) Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization. Gastroenterology 131(6):1913-1924.
13. Nakao K, et al. (2004) High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 25(8):1345-1357.
14. Garraway LA, Sellers WR (2006) Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 6(8):593-602.
15. Firestein R, et al. (2008) CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455(7212):547-551.
16. Veeriah S, et al. (2010) Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet 42(1):77-82.
17. Beroukhim R, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc Natl Acad Sci USA 104(50):20007-20012.
18. Slattery ML, et al. (2004) Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 13(7):1206-1214.
19. Jonsson J, Carlsson L, Edlund T, Edlund H (1994) Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371(6498):606-609.
20. Offield MF, et al. (1996) PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122(3):983-995.
21. Beroukhim R, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463(7283):899-905.
22. Rhodes DR, et al. (2007) Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9(2):166-180.
23. Chawengsaksophak K, James R, Hammond VE, Köntgen F, Beck F (1997) Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 386(6620):84-87.
24. Aoki K, Tamai Y, Horiike S, Oshima M, Taketo MM (2003) Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice. Nat Genet 35(4):323-330.
25. Bonhomme C, et al. (2003) The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut 52(10):1465-1471.
26. Wicking C, et al. (1998) CDX2, a human homologue of Drosophila caudal, is mutated in both alleles in a replication error positive colorectal cancer. Oncogene 17(5):657-659.
27. da Costa LT, et al. (1999) CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling. Oncogene 18(35):5010-5014.
28. Yagi OK, Akiyama Y, Yuasa Y (1999) Genomic structure and alterations of homeobox gene CDX2 in colorectal carcinomas. Br J Cancer 79(3-4):440-444.
29. Woodford-Richens KL, et al. (2001) CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers. Br J Cancer 84(10):1314-1316.
30. Subramanian A, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545-15550.
31. Mikels AJ, Nusse R (2006) Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4(4):e115.
32. Wang HQ, Xu ML, Ma J, Zhang Y, Xie CH (2012) Frizzled-8 as a putative therapeutic target in human lung cancer. Biochem Biophys Res Commun 417(1):62-66.
33. Gao Y, Wang HY (2006) Casein kinase 2 Is activated and essential for Wnt/beta-catenin signaling. J Biol Chem 281(27):18394-18400.
34. Berger MF, et al. (2008) Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences. Cell 133(7):1266-1276.
35. Traber PG, Wu GD, Wang W (1992) Novel DNA-binding proteins regulate intestine-specific transcription of the sucrase-isomaltase gene. Mol Cell Biol 12(8):3614-3627.
36. Suh E, Traber PG (1996) An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol 16(2):619-625.
37. Eda A, et al. (2003) Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol 38(1):14-22.
38. Hinoi T, et al. (2002) CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 123(5):1565-1577.
39. Matys V, et al. (2003) TRANSFAC: Transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31(1):374-378.
40. Verzi MP, et al. (2010) TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions. Proc Natl Acad Sci USA 107(34):15157-15162.
41. Boudreau F, et al. (2002) Hepatocyte nuclear factor-1 alpha, GATA-4, and caudal related homeodomain protein Cdx2 interact functionally to modulate intestinal gene transcription. Implication for the developmental regulation of the sucrase-isomaltase gene. J Biol Chem 277(35):31909-31917.
42. Benoit YD, et al. (2010) Cooperation between HNF-1alpha, Cdx2, and GATA-4 in initiating an enterocytic differentiation program in a normal human intestinal epithelial progenitor cell line. Am J Physiol Gastrointest Liver Physiol 298(4):G504-G517.
43. Guo RJ, Funakoshi S, Lee HH, Kong J, Lynch JP (2010) The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex. Carcinogenesis 31(2):159-166.
44. Bass AJ, et al. (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41(11):1238-1242.
45. Network TCGA; Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330-337.
46. Greenman C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446(7132):153-158.
47. Blyth K, Cameron ER, Neil JC (2005) The RUNX genes: Gain or loss of function in cancer. Nat Rev Cancer 5(5):376-387.
48. Chawengsaksophak K, de Graaff W, Rossant J, Deschamps J, Beck F (2004) Cdx2 is essential for axial elongation in mouse development. Proc Natl Acad Sci USA 101(20):7641-7645.
49. Beck F, Chawengsaksophak K, Waring P, Playford RJ, Furness JB (1999) Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc Natl Acad Sci USA 96(13):7318-7323.
50. Guo RJ, Suh ER, Lynch JP (2004) The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther 3(7):593-601.
51. Mutoh H, et al. (2002) Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun 294(2):470-479.
52. Silberg DG, et al. (2002) Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122(3):689-696.
53. Rawat VP, et al. (2004) Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia. Proc Natl Acad Sci USA 101(3):817-822.
54. Visakorpi T, et al. (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9(4):401-406.
55. Garraway LA, et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436(7047):117-122.
56. Kendall J, et al. (2007) Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci USA 104(42):16663-16668.
57. Weir BA, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450(7171):893-898.
58. Kwei KA, et al. (2008) Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 27(25):3635-3640.
59. Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434(7035):843-850.
60. Thorstensen L, et al. (2005) Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia 7(2):99-108.
61. Kobayashi M, et al. (2000) Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer 82(10):1689-1693.
62. Pollack JR, et al. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23(1):41-46.
63. Pollack JR, et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99(20):12963-12968.
64. Olshen AB, Venkatraman ES, Lucito R, Wigler M (2004) Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5(4):557-572.
65. Reich M, et al. (2006) GenePattern 2.0. Nat Genet 38(5):500-501.
66. Valouev A, et al. (2008) Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data. Nat Methods 5(9):829-834.